Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

Clinical trial NCT04927793 · COMPLETED

Trial details

NCT number: NCT04927793
Sponsor: Enanta Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2021-05-28
Primary completion: 2021-07-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.